EP1991569A4 - Molécules biologiques mammaliennes à glycosylation naturelle produites par stimulation électromagnétique de cellules mammaliennes vivantes - Google Patents

Molécules biologiques mammaliennes à glycosylation naturelle produites par stimulation électromagnétique de cellules mammaliennes vivantes

Info

Publication number
EP1991569A4
EP1991569A4 EP06748309A EP06748309A EP1991569A4 EP 1991569 A4 EP1991569 A4 EP 1991569A4 EP 06748309 A EP06748309 A EP 06748309A EP 06748309 A EP06748309 A EP 06748309A EP 1991569 A4 EP1991569 A4 EP 1991569A4
Authority
EP
European Patent Office
Prior art keywords
eletromagnetically
biological molecules
molecules produced
mammalian cells
natively glycosylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06748309A
Other languages
German (de)
English (en)
Other versions
EP1991569A2 (fr
Inventor
Thomas J Goodwin
Donnie Rudd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenetech Inc
National Aeronautics and Space Administration NASA
Original Assignee
Regenetech Inc
National Aeronautics and Space Administration NASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenetech Inc, National Aeronautics and Space Administration NASA filed Critical Regenetech Inc
Publication of EP1991569A2 publication Critical patent/EP1991569A2/fr
Publication of EP1991569A4 publication Critical patent/EP1991569A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP06748309A 2006-03-07 2006-03-07 Molécules biologiques mammaliennes à glycosylation naturelle produites par stimulation électromagnétique de cellules mammaliennes vivantes Withdrawn EP1991569A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/008071 WO2007102812A2 (fr) 2006-03-07 2006-03-07 Molécules biologiques mammaliennes à glycosylation naturelle produites par stimulation électromagnétique de cellules mammaliennes vivantes

Publications (2)

Publication Number Publication Date
EP1991569A2 EP1991569A2 (fr) 2008-11-19
EP1991569A4 true EP1991569A4 (fr) 2009-12-23

Family

ID=38475285

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06748309A Withdrawn EP1991569A4 (fr) 2006-03-07 2006-03-07 Molécules biologiques mammaliennes à glycosylation naturelle produites par stimulation électromagnétique de cellules mammaliennes vivantes

Country Status (4)

Country Link
EP (1) EP1991569A4 (fr)
CN (1) CN101213206A (fr)
IL (1) IL188396A0 (fr)
WO (1) WO2007102812A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944019B1 (fr) * 2009-04-03 2011-04-22 Biomerieux Sa Procede de dosage de la prodefensine-a6 pour le diagnostic in vitro du cancer colorectal.
WO2013148147A1 (fr) 2012-03-26 2013-10-03 The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services Analyse de la méthylation de l'adn à des fins diagnostiques, pronostiques et thérapeutiques des néoplasies des glandes surrénales
KR20180081821A (ko) 2015-12-03 2018-07-17 더 브리검 앤드 우먼즈 하스피털, 인크. 기능적 조혈 줄기 세포를 생성하는 방법
CN107541790B (zh) * 2016-06-24 2021-07-06 上海交通大学 一种糖基化检测的人凝集素/类人凝集素芯片及制备方法
CN113252616B (zh) * 2021-01-29 2022-05-03 厦门大学 一种外泌体的糖基化研究方法
CN118147232A (zh) * 2024-05-09 2024-06-07 中国人民解放军联勤保障部队第九二〇医院 一种过表达tps1间充质干细胞的构建方法及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003520A1 (fr) * 1984-12-04 1986-06-19 Genetics Institute, Inc. Methode de production de l'erythropoietine
GB2169312A (en) * 1985-01-02 1986-07-09 Beaconsfield Tina A method for producing proteins
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348191B1 (en) * 1986-07-08 2002-02-19 Genetics Institute, Inc. Production and use of IL-6
US20070048253A1 (en) * 2004-06-30 2007-03-01 Goodwin Thomas J Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003520A1 (fr) * 1984-12-04 1986-06-19 Genetics Institute, Inc. Methode de production de l'erythropoietine
GB2169312A (en) * 1985-01-02 1986-07-09 Beaconsfield Tina A method for producing proteins
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FISHER S J ET AL: "EFFECT OF A PULSED ELECTROMAGNETIC FIELD ON PLASMA MEMBRANE PROTEIN GLYCOSYLATION", JOURNAL OF BIOELECTRICITY, vol. 5, no. 2, 1986, pages 253 - 268, XP009125275, ISSN: 0730-823X *
HOGLUND M: "GLYCOSYLATED AND NON-GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) - WHAT IS THE DIFFERENCE?", MEDICAL ONCOLOGY, SCIENCE AND TECHNOLOGY LETTERS, NORTHWOOD, GB, vol. 15, no. 4, 1 December 1998 (1998-12-01), pages 229 - 233, XP009027777, ISSN: 1357-0560 *
KUBOTA N ET AL: "Structural characterization of natural and recombinant human granulocyte colony-stimulating factors.", JOURNAL OF BIOCHEMISTRY MAR 1990, vol. 107, no. 3, March 1990 (1990-03-01), pages 486 - 492, XP009125309, ISSN: 0021-924X *
LELKES P I ET AL: "GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells.", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL MAY 1997, vol. 33, no. 5, May 1997 (1997-05-01), pages 344 - 351, XP002553931, ISSN: 1071-2690 *

Also Published As

Publication number Publication date
CN101213206A (zh) 2008-07-02
WO2007102812A9 (fr) 2008-02-21
WO2007102812A3 (fr) 2007-12-21
EP1991569A2 (fr) 2008-11-19
IL188396A0 (en) 2008-08-07
WO2007102812A2 (fr) 2007-09-13

Similar Documents

Publication Publication Date Title
IL285655B (en) A system for identifying bacteria in biological samples
HK1246827A1 (zh) 細胞培養方法
PL2326349T3 (pl) Nowe reagenty i sposób sprzęgania cząsteczek biologicznych
SG10201510384UA (en) Cell culture improvements
EP2480897A4 (fr) Système pour conduire l'identification de bactéries dans des échantillons biologiques
EP2300880A4 (fr) Analyse d'objets biologiques transparents
EP2028264A4 (fr) Incubateur de cellules
GB0617983D0 (en) Biological fluid analysis system
EP2011857A4 (fr) Procédé de production de récipient pour culture cellulaire
GB0525579D0 (en) Cell culture vessel
EP2346387B8 (fr) Analyse de sang
EP2128242A4 (fr) Module de culture cellulaire
IL184262A (en) A method for culturing cells in culture
IL188396A0 (en) Natively glycosylated mammalian biological molecules prouced by eletromagnetically stimulating living mammalian cells
GB0517382D0 (en) Cell culture
GB0808373D0 (en) Scalable cell culture bioreactor and cell culture process
EP2336355A4 (fr) Procédé de prédiction de rythme biologique
EP2118297A4 (fr) Génération de molécules d'acide nucléique
EP2185720A4 (fr) Codage biologique d'un grand nombre de cellules
EP2196194A4 (fr) Procédé de production d'ingesta biologiques et ingesta biologiques obtenus par celui-ci
GB0606764D0 (en) Three dimensional cell culture
BRPI0719262A2 (pt) Transformação genética metabólica de células de leveduras fermentadoras de arabinose
GB0813339D0 (en) Novel reagents and method for conjugating biological molecules
AU2007901277A0 (en) Analysis of Ribonucleic Acid
GB0905762D0 (en) Novel reagents and method for conjugating biological molecules

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080124

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091120

17Q First examination report despatched

Effective date: 20100310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100921